Intellia Therapeutics
NTLA
#5608
Rank
NZ$2.49 B
Marketcap
NZ$17.78
Share price
-0.81%
Change (1 day)
18.57%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2026 (TTM): NZ-$5.84

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$6.11. In 2025 the company made an earnings per share (EPS) of NZ-$6.96 an increase over its 2024 EPS that were of NZ-$9.55.

EPS history for Intellia Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.84-16.17%
2025NZ-$6.96-27.05%
2024NZ-$9.55-2.96%
2023NZ-$9.84-12.46%
2022NZ-$11.2464.36%
2021NZ-$6.8456.67%
2020NZ-$4.36
2018NZ-$3.626.99%
2017NZ-$3.3871.4%
2016NZ-$1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.45-59.82%๐Ÿ‡บ๐Ÿ‡ธ USA